Aarhus, Denmark (February 1st, 2019) – Kim Mouridsen, PhD, Head of Neuroimaging Methods at the Center of Functionally Integrative Neuroscience (CFIN) and the founder of Cercare Medical, has been appointed Professor at Aarhus University.

From Math to AI in Neuroimaging

It started with the childhood dream of becoming a medical doctor, but Kim Mouridsen’s life path took a different turn when he was spotted as a mathematical talent in high school. His teacher encouraged him to specialize in mathematics which Kim Mouridsen did. But he didn’t stop there – specializing in statistics was next.

Before getting his degree, he anticipated working in the financial sector when he learned about a position at CFIN. CFIN’s director Professor Leif Østergaard explained to Kim an exciting idea to use mathematics to improve diagnosis.

At CFIN Kim immediately started working on developing robust methodology for assessing not only tissue perfusion but also oxygen availability in close collaboration with Professor Leif Østergaard and testing the validity and potential strength of perfusion and oxygenation biomarkers in a variety of diseases, focusing firstly on ischemic stroke, but also in other important clinical settings. Combined with parallel development in AI technology, his extensive research signified a breakthrough in modern neuroimaging analysis, making Kim Mouridsen one of the world leading researchers in AI and its implementation in stroke.

Applying Research to Clinical Practice

Cercare Medical Neurosuite is one of Professor Mouridsen’s achievements. Based on novel imaging markers and AI, Cercare Medical Neurosuite allows for comprehensive analysis of brain diseases with vascular pathology and stroke patient management. With time being a crucial factor for stroke patient’s recovery, a fast and well-founded decision and onset of treatment makes a world of difference. And that is what Cercare Medical Neurosuite facilitates. As Professor Mouridsen puts it,

“I am happy that my dream to help people has come true, even though it took an unexpected turn. It’s a good feeling that my research has become more than a scientific paper. It really concerns me that so many innovative ideas in research do not make it to market. It is still a very big problem, in my opinion, and I will keep working on making new technologies available to patients.”

Professor Mouridsen is also lecturing in AI at Aarhus University and the Chinese Academy of Sciences in Beijing. “Machine learning is developing with the speed of light in different areas of our lives,” says Mouridsen. “At Aarhus University, only 4 students took the course when we started ten years ago. Today, the number is 40 which is not surprising. Artificial intelligence is expected to have a fundamental impact on the healthcare system by utilizing data to optimize workflows and minimize costs of routine tasks, while improving patient management as part of future Personalized Medicine. Sooner than we know it, AI will become a standard in the healthcare industry.”

 

Watch Kim presenting Cercare Medical Neurosuite at Philips HealthWorks Breakthrough Day

The Next Step: AI for Prediction of Disease Progression and Response to Treatment

In his new position, Professor Mouridsen is planning to continue his research focusing on the expansion of AI-based models to new cohorts, extending AI-based patient management to routine care, early detection of cancer and stroke progression assessment.

The ambition is to take AI further than identifying a disease by predicting disease progression, and thereby, simultaneously, obtain flexible tools for understanding disease mechanisms. “With the growing availability of imaging (and other) biomarkers, it becomes increasingly difficult for treating physicians to combine the wealth of biomarkers into simpler, useful metrics to be used in their patient management,” says Mouridsen.

“Utilizing the growing databases of patient information in combination with acute imaging gives us the opportunity or maybe even the duty to begin using computers to identify early disease signals and predict the progression of diseases – and possibly even predict the effects of particular interventions in individual patients.”

We congratulate Kim Mouridsen on his promotion and look forward to seeing him bring his ideas to life with our solutions.

Would you like to know more about Kim Mouridsen’s research? Visit our resource page or sign up for our newsletter.

###

 

Contact for journalists

Tatiana Karpenko, Cercare Medical

Email: tk@cercare-medical.com